Ulcerative Colitis: Epidemiology Forecast to 2026 - Update
Summary
Ulcerative colitis (UC) is an inflammatory bowel disease (IBD) characterized by long-lasting inflammation and ulcers (sores) in the lining of the colon. UC is limited to the colon and has less frequent complications.
The author’s epidemiological forecast for the diagnosed incidence, diagnosed prevalence, undiagnosed prevalence, and total prevalence of UC in the 7MM is supported by nationally representative, country-specific studies published in peer-reviewed journals of national healthcare databases and registries. In addition, to improve the comparability of the forecast diagnosed incident and diagnosed prevalent cases of UC across markets, epidemiologists used sources that provided uniform diagnostic criteria for these subcategories.
In the 7MM, the diagnosed incident cases of UC are expected to increase from 94,303 cases in 2016 to 108,428 cases in 2026, at an Annual Growth Rate (AGR) of 1.5%. The US will have the highest number of diagnosed incident cases of UC over the forecast period, while Spain will have the lowest. In the 7MM, the diagnosed prevalent cases of UC are expected to increase from 1,737,130 cases in 2016 to 1,867,305 cases in 2026, at an AGR of 0.75%. The US will have the highest number of diagnosed prevalent cases of UC over the forecast period, while Spain will have the lowest.
This Update includes revised severity segmentation section in the report and reorganization of severity segmentations in the model.
Scope
Reasons to Buy
Develop business strategies by understanding the trends shaping and driving the global UC market.
Understand magnitude of UC population by severity, stage at diagnosis, comorbidities, and other clinically relevant segmentations.
Summary
Ulcerative colitis (UC) is an inflammatory bowel disease (IBD) characterized by long-lasting inflammation and ulcers (sores) in the lining of the colon. UC is limited to the colon and has less frequent complications.
The author’s epidemiological forecast for the diagnosed incidence, diagnosed prevalence, undiagnosed prevalence, and total prevalence of UC in the 7MM is supported by nationally representative, country-specific studies published in peer-reviewed journals of national healthcare databases and registries. In addition, to improve the comparability of the forecast diagnosed incident and diagnosed prevalent cases of UC across markets, epidemiologists used sources that provided uniform diagnostic criteria for these subcategories.
In the 7MM, the diagnosed incident cases of UC are expected to increase from 94,303 cases in 2016 to 108,428 cases in 2026, at an Annual Growth Rate (AGR) of 1.5%. The US will have the highest number of diagnosed incident cases of UC over the forecast period, while Spain will have the lowest. In the 7MM, the diagnosed prevalent cases of UC are expected to increase from 1,737,130 cases in 2016 to 1,867,305 cases in 2026, at an AGR of 0.75%. The US will have the highest number of diagnosed prevalent cases of UC over the forecast period, while Spain will have the lowest.
This Update includes revised severity segmentation section in the report and reorganization of severity segmentations in the model.
Scope
- The Ulcerative Colitis (UC) Epidemiology Forecast Report and Epidemiology Forecast Model provide an overview of the risk factors and global trends of UC in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan).
- This report also includes a 10-year epidemiological forecast for the diagnosed incident cases, diagnosed prevalent cases, undiagnosed prevalent cases, and total prevalent cases (both diagnosed and undiagnosed) of UC, segmented by sex and age (starting at ages 0-9 years and ending at ages 80 years and older) in these markets. The diagnosed incident cases are further segmented by stage at diagnosis and severity grading. The diagnosed prevalent cases are further segmented by severity grading. Additionally, autoimmune comorbidities, colectomy due to failure of medical management, and mortality due to complications of UC among the diagnosed prevalent cases of UC are also included in this analysis. Furthermore, the report includes diagnosed incident cases and diagnosed prevalent cases of indeterminate colitis (IC) for both sexes and all ages in the 7MM.
- The Ulcerative Colitis epidemiology forecast report and model were written and developed by Masters- and PhD-level epidemiologists.
- The Epidemiology Forecast Report is in-depth, high quality, transparent, and market-driven, providing expert analysis of disease trends in the 7MM.
- The Epidemiology Forecast Model is easy to navigate, interactive with dashboards, and epidemiology-based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over a 10-year forecast period using reputable sources.
Reasons to Buy
- The Ulcerative Colitis (UC) Epidemiology Forecast series will allow you to:
Develop business strategies by understanding the trends shaping and driving the global UC market.
- Quantify patient populations in the global UC market to improve product design, pricing, and launch plans.
- Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for UC therapeutics in each of the markets covered.
Understand magnitude of UC population by severity, stage at diagnosis, comorbidities, and other clinically relevant segmentations.
Table of Contents
1 Table of Contents1.1 List of Tables
1.2 List of Figures
2 Ulcerative Colitis: Executive Summary
2.1 Related Reports
2.2 Upcoming Reports
3 Epidemiology
3.1 Disease Background
3.2 Risk Factors and Comorbidities
3.3 Global and Historical Trends
3.4 Forecast Methodology
3.4.1 Sources
3.4.2 Forecast Assumptions and Methods
3.5 Epidemiological Forecast for UC (2016-2026)
3.5.1 Diagnosed Incident Cases of UC
3.5.2 Age-Specific Incident Cases of UC
3.5.3 Sex-Specific Incident Cases of UC
3.5.4 Diagnosed Incident Cases of UC by Stage at Diagnosis
3.5.5 Diagnosed Incident Cases of UC by Severity
3.5.6 Diagnosed Prevalent Cases of UC
3.5.7 Age-Specific Diagnosed Prevalent Cases of UC
3.5.8 Sex-Specific Diagnosed Prevalent Cases of UC
3.5.9 Diagnosed Prevalent Cases of UC by Severity (PMR and Literature Data)
3.5.10 Diagnosed Prevalent Cases of UC by Severity Alternate Forecast (Literature Data)
3.5.11 Mortality Due to Complications Among the Diagnosed Prevalent Cases of UC
3.5.12 Colectomy Due to Failure of Medical Management Among the Diagnosed Prevalent Cases of UC
3.5.13 Comorbidities of UC Among the Diagnosed Prevalent Cases of UC
3.5.14 Undiagnosed Prevalent Cases of UC
3.5.15 Total Prevalent Cases of UC
3.5.16 Diagnosed Incident Cases of IC
3.5.17 Diagnosed Prevalent Cases of IC
3.6 Discussion
3.6.1 Epidemiological Forecast Insight
3.6.2 Limitations of Analysis
3.6.3 Strengths of Analysis
4 Appendix
4.1 Bibliography
4.2 Primary Research - KOLs Interviewed for this Report
4.3 About the Authors
4.3.1 Epidemiologist
4.3.2 Reviewers
4.3.3 Global Director of Therapy Analysis and Epidemiology
4.3.4 Global Head and EVP of Healthcare Operations and Strategy
4.4 About the Author
4.5 Contact Us
4.6 Disclaimer
List of Tables
- Table 1: Risk Factors and Comorbidities for UC and IBD
List of Figures
- Figure 1: 7MM, Diagnosed Incident Cases of UC, Both Sexes, All Ages, N, 2016 and 2026
- Figure 2: 7MM, Diagnosed Prevalent Cases of UC, Both Sexes, All Ages, N, 2016 and 2026
- Figure 3: 7MM, Age-Standardized Diagnosed Incidence of UC (Cases per 100,000 Population), All Ages, Both Sexes, N, 2016
- Figure 4: 7MM, Age-Standardized Diagnosed Prevalence of UC (%), All Ages, Both Sexes, N, 2016
- Figure 5: 7MM, Sources Used, Diagnosed Incident Cases of UC
- Figure 6: 7MM, Sources Used, Diagnosed Prevalent Cases of UC
- Figure 7: 7MM, Sources Used, Undiagnosed Prevalent Cases of UC
- Figure 8: 7MM, Sources Used, Total Prevalent Cases of UC
- Figure 9: 7MM, Sources Used, Diagnosed Incident Cases of UC by Stage at Diagnosis
- Figure 10: 7MM, Sources Used, Diagnosed Incident Cases of UC by Severity
- Figure 11: 7MM, Sources Used, Diagnosed Prevalent Cases of UC by Severity, Adults, Alternate Forecast (Literature Data)
- Figure 12: 7MM, Sources Used, Mortality Due to CRC and TMC Among the Diagnosed Prevalent Cases of UC
- Figure 13: 7MM, Sources Used, UC Cases Requiring Colectomy Among the Diagnosed Prevalent Cases of UC Due to Failure of Medical Management
- Figure 14: 7MM, Sources Used, Diagnosed Incident Cases of IC
- Figure 15: 7MM, Sources Used, Diagnosed Prevalent Cases of IC
- Figure 16: Diagnosed Incident Cases of UC, 7MM, Men and Women, All Ages, 2016
- Figure 17: 7MM, Age-Specific Diagnosed Incident Cases of UC, Both Sexes, N, 2016
- Figure 18: 7MM, Sex-Specific Diagnosed Incident Cases of UC, All Ages, N, 2016
- Figure 19: 7MM, Diagnosed Incident Cases of UC Segmented by Stage at Diagnosis, Both Sexes, All Ages, N, 2016
- Figure 20: 7MM, Diagnosed Incident Cases of UC Segmented by Severity, Both Sexes, All ages, N, 2016
- Figure 21: Diagnosed Prevalent Cases of UC, 7MM, Men and Women, All Ages, 2016
- Figure 22: 7MM, Age-Specific Diagnosed Prevalent Cases of UC, Both Sexes, N, 2016
- Figure 23: 7MM, Sex-Specific Diagnosed Prevalent Cases of UC, All Ages, N, 2016
- Figure 24: 7MM, Diagnosed Prevalent Cases of UC by Severity, Both Sexes, ≥18 Years, N, 2016
- Figure 25: 7MM, Diagnosed Prevalent Cases of UC by Severity, Both Sexes, ≥18 Years, N, 2016
- Figure 26: 7MM, Mortality Due to Complications Among the Diagnosed Prevalent Cases of UC, Both Sexes, All Ages, N, 2016
- Figure 27: 7MM, Colectomy Due to Failure of Medical Management Among the Diagnosed Prevalent Cases of UC, Both Sexes, All Ages, N, 2016
- Figure 28: 7MM, Comorbidities Among the Diagnosed Prevalent Cases of UC, Both Sexes, All Ages, N, 2016
- Figure 29: Undiagnosed Prevalent Cases of UC, 7MM, Men and Women, All Ages, 2016
- Figure 30: Total Prevalent Cases of UC, 7MM, Men and Women, All Ages, 2016
- Figure 31: Diagnosed Incident Cases of IC, 7MM, Men and Women, All Ages, 2016
- Figure 32: Diagnosed Prevalent Cases of IC, 7MM, Men and Women, All Ages, 2016
